Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial evaluating the efficacy and safety of two atypical antipsychotics versus placebo in acute exacerbations of schizophrenia or sc…
-
CLINICAL_TRIALS trial_result · 2012-01-19Clinical Trial Update: Treatment of Schizophrenia and Comorbid Cannabis Use Disorder: Comparing Clozapine to Treatment-as-Usual [Phase 4]
A Phase 4 trial comparing clozapine to treatment-as-usual for schizophrenia with comorbid cannabis use disorder; study completed with posted…
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia [Phase 1]
A completed Phase 1 trial evaluating the effect of oral N-acetylcysteine on brain glutathione levels and schizophrenia symptom outcomes.
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Treatment for First-Episode Schizophrenia [Phase 4]
Phase 4 clinical trial update for a treatment of first-episode schizophrenia, conducted by Northwell Health, and the study has been complete…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Open-label Phase 3 study evaluating intramuscular olanzapine depot in patients with schizophrenia or schizoaffective disorder; results were …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-01-06Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in Schizophrenia [NA]
This clinical trial update examines repetitive transcranial magnetic stimulation for refractory auditory hallucinations in schizophrenia. Th…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition [Phase 1]
This clinical trial update reports the completion of a Phase 1 bioequivalence study of olanzapine orally disintegrating tablets (5 mg) under…
-
CLINICAL_TRIALS trial_result · 2012-01-05Clinical Trial Update: Minocycline as an Adjunctive Therapy for Schizophrenia: a Randomized Controlled Study [Phase 4]
A Phase 4 randomized controlled trial is evaluating minocycline as an adjunctive therapy for schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia [Phase 4]
A Phase 4 randomized study comparing paliperidone extended-release with risperidone in schizophrenia to assess neurocognitive function; the …
-
CLINICAL_TRIALS trial_result · 2011-12-16Clinical Trial Update: The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia [Phase 4]
A completed Phase 4 clinical trial evaluating minocycline for negative and cognitive symptoms in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-12-14Clinical Trial Update: Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect
A completed AstraZeneca study investigates how patient characteristics influence the therapeutic effects of atypical antipsychotics, includi…
-
CLINICAL_TRIALS trial_result · 2011-12-02Clinical Trial Update: Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode [Phase 4]
This Phase 4 clinical trial reports results for a long-acting injectable form of risperidone in patients with schizophrenia after an acute e…
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective Study
A completed prospective study evaluating infant development after in utero exposure to antipsychotics in pregnancies of women with schizophr…
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness [Phase 3]
Phase 3 trial assessing the impact of genetic counseling for female first-degree relatives of individuals with schizophrenia, bipolar disord…
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Study of the Efficacy and Safety of Quetiapine Fumarate Extended Release (Seroquel XR) [Phase 4]
Phase 4 clinical trial update assessing the efficacy and safety of quetiapine fumarate extended-release (Seroquel XR) in schizophrenia; resu…
-
CLINICAL_TRIALS trial_result · 2011-11-18Clinical Trial Update: Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia [NA]
This terminated clinical trial evaluated aggressive treatment of metabolic syndrome in patients with schizophrenia who are receiving clozapi…
-
CLINICAL_TRIALS trial_result · 2011-11-11Clinical Trial Update: Quetiapine XR in Schizophrenic Patients [Phase 3]
A Phase 3 trial of quetiapine XR for schizophrenia was terminated.
-
CLINICAL_TRIALS trial_result · 2011-11-07Clinical Trial Update: Hematological Clozapine Monitoring With a Point-of-care Device (CHEMPAQ)
This document reports a completed clinical trial evaluating a point-of-care hematological monitoring device (CHEMPAQ) for clozapine safety i…
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics [Phase 1]
A Phase 1 study evaluated AZD8529 for effects on cognition and negative symptoms in people with schizophrenia. The trial has been completed.
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Quetiapine Induced Neuroplasticity in First-episode Schizophrenic Patients [Phase 4]
A Phase 4 clinical trial evaluating quetiapine's effects on neuroplasticity in patients with first-episode schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2011-10-24Clinical Trial Update: Seroquel XR in the Long Term Treatment of Schizophrenia
A completed clinical trial evaluated quetiapine extended-release (Seroquel XR) for long-term treatment of schizophrenia to reduce relapse ri…
-
CLINICAL_TRIALS trial_result · 2011-10-17Clinical Trial Update: Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study [Phase 2]
Phase 2 clinical trial update of a GABA-A Alpha2/3 selective agent in schizophrenia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2011-10-14Clinical Trial Update: NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia
A clinical trial update from AstraZeneca reports monitoring improvement in Global Assessment of Functioning in patients with schizophrenia.
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia [Phase 3]
This document reports the results of a long-term safety Phase 3 study of lurasidone in clinically stable schizophrenia and schizoaffective d…
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia. [Phase 3]
Results from a 6-week Phase 3 trial of lurasidone hydrochloride for acute schizophrenia have been posted.